The Application of Biologically Active Components Derived from Mineral, Synthetic, Phyto- and Organic Sources for Developing Local Hemostatic Agents: Historical Traditions and Contemporary Advancements
DOI:
https://doi.org/10.12775/JEHS.2024.75.57568Keywords
bleeding, hemostatic agents, adsorbing materials, natural hemostaticsAbstract
The present paper aims to provide an overview of the use of biologically active components derived from mineral, synthetic, phyto-, and organic sources in the development of local hemostatic agents. The study highlights the historical and contemporary use of these agents in medical practice, and examines the scientific evidence supporting their efficacy.
Hemostasis, the process of stopping bleeding, is a critical component of surgical and medical procedures. Local hemostatic agents are widely used to achieve hemostasis in a targeted and controlled manner, thereby minimizing the risk of complications associated with bleeding.
The use of biologically active components derived from various sources, including minerals, synthetic materials, plants, and organic compounds, has a long history in the development of hemostatic agents. These components can act through various mechanisms, such as inducing platelet aggregation, activating the coagulation cascade, or promoting the formation of blood clots.
Recent advances in biotechnology and nanotechnology have led to the development of novel hemostatic agents with improved properties, such as enhanced biocompatibility, targeted delivery, and controlled release. These agents have the potential to revolutionize hemostasis in surgical and medical procedures, and improve patient outcomes.
Overall, the study highlights the importance of biologically active components derived from mineral, synthetic, phyto-, and organic sources in the development of local hemostatic agents. The review of historical and contemporary use of these agents underscores their continued relevance in medical practice, while recent advances in technology offer exciting new possibilities for future development.
After a thorough review of domestic and foreign literature, the development team used adsorbing materials from biologically active components of mineral, synthetic, phyto-, and organic origin to create a hemostatic powder known as "PLANTOR." The active components of PLANTOR include aerosol, carrageenan of a special brand, and a specific mixture of medicinal vegetable oils, which have a special sorption effect. Due to the well-selected composition of the product, PLANTOR forms a blood clot in the wound through a biophysical process of liquid absorption. Notably, PLANTOR does not contain procoagulant minerals or nanoparticles that could remain in the human body, and therefore does not belong to means with a chemical or biochemical mechanism of action.
Based on the above, it is possible to recommend the hemostatic agent-powder "PLANTOR" of the trade mark "PLANTOR tm" and "Dr. Sokolovskiy R" of the manufacturer "Medpro Nutraceuticals" (Latvia) by order of LLC "Plantor" (Ukraine, Dnipro), the author and owner of the developed technology of the hemostatic agent - powder "PLANTOR" (TU U 20.4-44827581-001:2022) as an auxiliary means of revitalization, local coagulation, treated wound surfaces during emergency medical care for external bleeding.
References
Annum Malik, &Fiza Ur Rehman, &Kifayat Ullah Shah, &Syeda Sohaila Naz, &Sarah Qaisar(2021).Hemostatic strategies for uncontrolled bleeding: A comprehensive update. Journal of Biomedical Materials Research, V.109 (10), 1465 – 1477.https://doi.org/10.1002/jbm.b.34806
Edward L. Mazuchowski, & Russ S. Kotwal, & Jud Janak [et al.] (2020).Mortality review of US Special Operations Command battle-injured fatalities.Journal of Trauma and Acute Care Surgery, 88(5), 686-695. DOI:10.1097/TA.0000000000002610
HuZhang, & ZhangDong-Ying, & LuSi-Tong [et al.] (2018).Chitosan-Based Composite Materials for Prospective Hemostatic Applications. Marine drugs, 16(8), 273 – 285.https://doi.org/10.3390/md16080273
Jeffrey T. Howard,& Russ S. Kotwal,&Caryn A. Stern [et al.] (2019).Use of Combat Casualty Care Data to Assess the US Military Trauma System During the Afghanistan and Iraq Conflicts, 2001-2017. JAMA Surgery, 154(7), 600-608.Doi:10.1001/jamasurg.2019.0151.
Lee Christopher, & Rasmussen Todd, & Pape Hans-Christoph [et al.] (2021).The polytrauma patient: Current concepts and evolving care.OTA International, V. 4(2S), 108 - 121. DOI:10.1097/OI9.0000000000000108
Lee Palmer(2022). Hemorrhage control—Proper application of direct pressure, pressure dressings, and tourniquets for controlling acute life-threatening hemorrhage. Journal of veterinary emergency and critical care, V. 32 (1), 32 – 47. https://doi.org/10.1111/vec.13116
Liang Huang, &Geoffrey L. Liu,Alan D. Kaye&Henry Liu(2020). Advances in Topical Hemostatic Agent Therapies: A Comprehensive Update.Advances in Therapy, 37, 4132 – 4148. https://doi.org/10.1007/s12325-020-01467-y
Li Xiang-Fei, & Lu Pengpeng , & JiaHao-Ran [et al.] (2023).Emerging materials for hemostasis.Coordination Chemistry Reviews, 475,https://doi.org/10.1016/j.ccr.2022.214823
Patrick Thompson, &Geir Strandenes(2019). The History of Fluid Resuscitation for Bleeding.Damage Control Resuscitation, 2548, 3 – 29.https://doi.org/10.1007/978-3-030-20820-2_1
Pedro GR Teixeira, & Carlos VR Brown, & Brent Emigh [et. al.] (2018).Civilian Prehospital Tourniquet Use Is Associated with Improved Survival in Patients with Peripheral Vascular Injury.Journal of the American College of Surgeons, V. 226 (5), 769 – 776.https://doi.org/10.1016/j.jamcollsurg.2018.01.047
Russ S. Kotwal, & Laura LF Scott, & Jud Janak [et al.] (2018).The effect of prehospital transport time, injury severity, and blood transfusion on survival of US military casualties in Iraq.Journal of Trauma and Acute Care Surgery, 85(1S), 112 – 121. DOI:10.1097/TA.0000000000001798.
Steven G. Schauer, & Jason F. Naylor, & Joshua J. Oliver, & Joseph K. Maddry, &Michael D. April(2019).An analysis of casualties presenting to military emergency departments in Iraq and Afghanistan.The American Journal of Emergency Medicine, V.37 (1), 94 - 99.https://doi.org/10.1016/j.ajem.2018.04.068
Verena Rass, & Raimund Helbok (2021).How to diagnose delayed cerebral ischaemia and symptomatic vasospasm and prevent cerebral infarction in patients with subarachnoid hemorrhage.Current Opinion in Critical Care, 27(2), 103 – 114.Doi10.1097/MCC.0000000000000798
Xiao-Xiong Wang, &Qi Liu, &Jin-Xia Sui, &Seeram Ramakrishna[et al.] (2019).Recent Advances in Hemostasis at the Nanoscale. Advanced healthcare materials, V. 23 (8), 321 – 333.https://doi.org/10.1002/adhm.201900823
YKSung, & DR Lee, & DJ Chung (2021). Advances in the development of hemostatic biomaterials for medical application.Biomaterials Research. 37(25), 1-10.https://doi.org/10.1186/s40824-021-00239-1
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 S. Abramov, S. Sokolovskyi, A. Gozhenko, I. Sobko, G. Titov, V. Gladyshev, M. Khmil, Ugis Kletnieks
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 40
Number of citations: 0
